3Biotech

02/06/2018

We moved to our new office.
We are now at WeWork, 40 rue du Colisée, 75008 Paris. Hope to see you soon and have a coffee in this very dynamic and cosy environment.

12/07/2017

An article describing the development of ACT017, a first in class antithrombotic agent developped by Acticor-Biotech :
http://www.tandfonline.com/doi/full/10.1080/19420862.2017.1336592

(2017). Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks. mAbs. Ahead of Print. doi: 10.1080/19420862.2017.1336592

15/02/2017

Meet 3Biotech at BIO International Convention in San Diego! 3Biotech will be represented by Olivier Favre-Bulle at BIO International Convention in San Diego. If you are looking for expertise in CMC, Drug development, MedTech development, we can arrange an appointment with you during the meeting. http://convention.bio.org/

19/03/2016

3Biotech will attend Bio International Convention at San Francisco in june. Let's meet there and talk how we can help you.

05/10/2015

3Biotech will attend BioProcess International congress at Boston, october 26-29 2015.

11/05/2015

3Biotech will attend the Third Annual European CMO consulting Summit in Copenhagen , 19-21 May. This summit is organized by CMC Biologics.

01/04/2015

We are selected for Biovision catalyzer.

3Biotech has been selected to represent the project "Radical Imaging" at the Biovision Catalyzer the 15-16th of April at Lyon. Radical Imaging is an innovative project in the metabolic imaging to detect cancers via Magnetic Resonance Imaging.

The selection committees have identified 25 companies seeking funding for the Investor Conference and 25 innovative projects for the Catalyzer session.

27/01/2015

3Biotech will at Bio-Europe 2015 the 9-11 of March at Paris

07/01/2015

Je ne suis pas d'accord avec ce que vous dites, mais je me battrai pour que vous ayez le droit de le dire.
Voltaire